NEW YORK, Aug. 6 - PreAnalytix, a Swiss-based joint venture between Qiagen and Becton Dickinson, has signed on GlaxoSmithKline as a new customer for its molecular-testing tools, PreAnalytix said yesterday.
The company's first product, the PaxGene Blood RNA system, is designed to help gene analysis of blood samples. It was launched in April 2001.
PreAnalytix, based in Hombrechtikon, is privately owned.